# Medical Technology Enterprise Consortium

Grantmaking public charity, North Bethesda, Maryland. EIN 47-4960128.

Source: the foundation’s own IRS returns, read November 20, 2026, as shown by the Alleviate Index. https://sites.alleviate.org/index/funder/medical-technology-enterprise-consortium-474960128

## Applications

Schedule I of Form 990 lists the grants made, not how to apply, so this return does not say whether Medical Technology Enterprise Consortium accepts applications.

## What it gave

- Grants paid: $980,254 (Year ending December 2024)
- Grants listed: 9 (To organizations, on that return)
- Typical grant: $37,000 (Half fall between $12,500 and $50,000)

- December 2024: Grants paid $980,254; Grants listed 9
- December 2023: Grants paid $1,402,910; Grants listed 22

From Schedule I of its Form 990 returns for the years ending December 2023 to December 2024.

## What it funds, and where

- Focus, by share of linked grant dollars: Mental health 40%, Science 27%, Medical research 27%, Public benefit 5%
- Where it gave, by number of grants: Massachusetts 5, California 3, Maryland 3, Virginia 3, Ohio 2, Pennsylvania 2, District of Columbia 2, Utah 1, Kentucky 1, Arizona 1, Colorado 1, Washington 1

## Recent grants to organizations

- Sense Diagnostics Inc (Cincinnati, Ohio): $242,500, year ending December 2024. Military Impact Project Award & Commercialization Grant
- Moberg Analytics (Philadelphia, Pennsylvania): $50,000, year ending December 2024. Commercialization Grant
- Purgo Scientific (S Jordan, Utah): $50,000, year ending December 2024. Commercialization Grant
- Vistendo Inc (Arcadia, California): $50,000, year ending December 2024. Commercialization Grant
- [American Psychiatric Association Foundation](https://sites.alleviate.org/index/org/american-psychiatric-association-foundation-130433740) (Washington, District of Columbia): $37,000, year ending December 2024. Provided a sponsorship and a scholarship
- Limax Biosciences Inc (Somerville, Massachusetts): $12,500, year ending December 2024. Commercialization Grant
- Matregenix Inc: $12,500, year ending December 2024. Commercialization Grant
- NIRSense LLC: $12,500, year ending December 2024. Commercialization Grant
- Sonogen Medical Inc: $12,500, year ending December 2024. Commercialization Grant
- International Fabric Machines (Boston, Massachusetts): $175,000, year ending December 2023. See Part IV
- University of Kentucky Research Foundation (Lexington, Kentucky): $139,086, year ending December 2023. See Part IV
- Surgibox Inc (Cambridge, Massachusetts): $128,500, year ending December 2023. See Part IV
- Sense Diagnostics Inc (Cincinnati, Ohio): $112,500, year ending December 2023. See Part IV
- Delta Development Team Inc (Tucson, Arizona): $111,854, year ending December 2023. See Part IV
- Perceptive Medical Inc (Newport Beach, California): $100,000, year ending December 2023. See Part IV
- TDA Research Inc (Wheat Ridge, Colorado): $63,539, year ending December 2023. See Part IV
- [Geneva Foundation 04-15-93](https://sites.alleviate.org/index/org/geneva-foundation-04-15-93-911593913) (Tacoma, Washington): $50,000, year ending December 2023. See Part IV
- [Henry M Jackson Foundation for the Advancement of Military Medicine](https://sites.alleviate.org/index/org/henry-m-jackson-foundation-for-the-advancement-of-military-521317896) (Bethesda, Maryland): $50,000, year ending December 2023. See Part IV
- Diagnostic Biochips Inc (Glen Burnie, Maryland): $37,500, year ending December 2023. See Part IV
- Limax Biosciences Inc (Somerville, Massachusetts): $37,500, year ending December 2023. See Part IV
- Matregenix Inc (Irvine, California): $37,500, year ending December 2023. See Part IV
- NIRSense LLC (Richmond, Virginia): $37,500, year ending December 2023. See Part IV
- Sonogen Medical Inc (Chevy Chase, Maryland): $37,500, year ending December 2023. See Part IV
- [American Psychiatric Association Foundation](https://sites.alleviate.org/index/org/american-psychiatric-association-foundation-130433740) (Washington, District of Columbia): $37,000, year ending December 2023. See Part IV
- Astrocyte Pharmaceuticals Inc (Groton, Connecticut): $31,211, year ending December 2023. See Part IV

Method and sources: https://sites.alleviate.org/index/method#funders
